Comments on: IPOs: Biotech ChemoCentryx and specialty-pharma Xanodyne head for the public market http://venturebeat.com/2007/11/12/ipos-biotech-chemocentryx-and-specialty-pharma-xanodyne-head-for-the-public-market/ News About Tech, Money and Innovation Tue, 24 Nov 2009 06:27:18 +0000 http://wordpress.org/?v=2.8.5 hourly 1 By: VentureBeat » Chemokine-drug maker ChemoCentryx files for $58M IPO http://venturebeat.com/2007/11/12/ipos-biotech-chemocentryx-and-specialty-pharma-xanodyne-head-for-the-public-market/comment-page-1/#comment-630548 VentureBeat » Chemokine-drug maker ChemoCentryx files for $58M IPO Tue, 13 Nov 2007 17:13:19 +0000 http://venturebeat.com/2007/11/12/ipos-chemocentryx-and-xanodyne-head-for-the-public-market/#comment-630548 [...] our story about this Mountain View, Calif., biotech in Monday’s daily briefing at VentureBeat Life Sciences. Tagged N/A VentureBeat [...] [...] our story about this Mountain View, Calif., biotech in Monday’s daily briefing at VentureBeat Life Sciences. Tagged N/A VentureBeat [...]

]]>